10-Q: Aeluma Q3 2026 Financial Results and Operational Update
Quarterly Report
Aeluma reports increased revenue and expanded R&D investment while addressing internal control deficiencies in its Q3 2026 10-Q filing.
Summary
- Revenue for the nine months ended March 31, 2026, reached $3.9 million, a 16% increase compared to the same period in 2025.
- Net loss for the nine months ended March 31, 2026, was $5.1 million, compared to a $2.2 million loss in the prior year period.
- Operating expenses rose 114% to $9.7 million, driven by increased headcount and R&D activities.
- Cash and cash equivalents totaled $37.8 million as of March 31, 2026, bolstered by public offerings.
- The company entered into five new government contracts during the nine-month period.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral report; while the company has a strong cash position to fund operations, the ineffective internal controls and widening losses highlight significant execution risks.
Positives
- Strong liquidity position with $37.8 million in cash and cash equivalents.
- Revenue growth of 16% year-over-year for the nine-month period.
- Successful completion of two public offerings raising significant capital.
- Expansion of R&D and manufacturing capabilities with a new facility lease.
Negatives
- Net loss widened to $5.1 million from $2.2 million in the prior year period.
- Operating expenses more than doubled, significantly outpacing revenue growth.
- Disclosure controls and procedures were deemed ineffective as of March 31, 2026.
- High concentration of revenue from a small number of government customers.
Risks
- Ineffective internal controls over financial reporting could lead to errors or fraud.
- Limited operating history and development-stage status create uncertainty regarding future profitability.
- Potential for U.S. federal government shutdowns to disrupt operations and funding.
- Dependence on a small number of government agencies for the majority of revenue.
- Risks associated with being an issuer of penny stock, including potential loss of safe harbor protections.
Future Outlook
The company intends to continue investing in R&D, expanding headcount, and maturing manufacturing processes to support commercialization and high-volume market entry.
Management Comments
- Management acknowledges that disclosure controls and procedures were not effective as of March 31, 2026, due to insufficient finance department staffing.
- Management is actively implementing mitigating measures and recruiting additional accounting personnel to remediate control deficiencies.
Industry Context
StockSavvy.ai notes that Aeluma is operating in a highly competitive semiconductor niche, where scaling from R&D to volume production is a common hurdle for emerging players. The reliance on government contracts is typical for early-stage deep-tech firms but creates significant customer concentration risk.
Comparison to Industry Standards
- Revenue growth is consistent with early-stage semiconductor firms, though operating losses are elevated due to aggressive R&D scaling.
- The company's reliance on government contracts is higher than typical commercial-focused semiconductor peers.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Remediation | Management is actively working to improve disclosure controls and procedures and documentation standards. | Ongoing | Necessary to ensure accurate financial reporting and regulatory compliance. |
Legal Proceedings
- None currently involved in material legal proceedings.
Related Party Transactions
- None disclosed.
Stakeholder Impact
- Shareholders face potential dilution from the at-the-market offering program.
- Employees benefit from continued investment in R&D and facility expansion.
Next Steps
- Continue recruitment of accounting personnel to remediate internal control deficiencies.
- Execute on government contracts and expand commercial business development.
- Monitor capital market conditions for potential use of the at-the-market offering program.
Key Dates
| Date | Description |
|---|---|
| 2025-03-25 | Conversion of convertible notes into common stock. |
| 2025-09-19 | Completion of underwritten public offering. |
| 2026-03-20 | Entry into an at-the-market sales agreement for up to $50 million. |
| 2026-03-31 | End of the quarterly reporting period. |
Recommendation
holdThe company has a strong cash runway, but the ineffective internal controls and high cash burn rate suggest investors should wait for evidence of improved financial reporting and progress toward commercialization before increasing exposure.
Keywords
semiconductor, optoelectronic, photodetectors, government contracts, R&D, semiconductor manufacturing, ALMU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.